Skip to main content
. 2019 Sep 6;34(1):e23028. doi: 10.1002/jcla.23028

Figure 2.

Figure 2

Expression of SMAD3 and miR‐145 in human aortic samples in the non‐AD control and AD groups, respectively. A and B, Immunoblot demonstrated the amounts of the SMAD3 protein in human aortic samples (n = 4 per group). The AD group showed significantly increased SMAD3 amounts (P < .01). C, qPCR demonstrated the expression of SMAD3 mRNA in human aortic samples (n = 6 and 4 for the AD and non‐AD control groups, respectively). The expression of SMAD3 mRNA significantly increased in the AD group (P < .01). D, qPCR was employed to assess miR‐145 amounts in human aortic samples (n = 6 and 4 for the AD and non‐AD control groups, respectively). miR‐145 amounts were markedly downregulated in the AD group (P < .05)